✦ LIBER ✦

Can we eliminate placebo in ALS clinical Trials?

✍ Scribed by Zachary Simmons

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 76 KB
Volume: 39
Category: Article
ISSN: 0148-639X
DOI: 10.1002/mus.21358

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

What can we learn from failed clinical t

What can we learn from failed clinical trials in multiple sclerosis?

✍ Tjalf Ziemssen 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 153 KB

Importance of Placebo Effect in Cough Cl

Importance of Placebo Effect in Cough Clinical Trials

✍ Ron Eccles 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 249 KB

Placebo-controlled clinical trials in mu

Placebo-controlled clinical trials in multiple sclerosis: Ethical considerations

✍ Fred D. Lublin; Stephen C. Reingold 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

Antidepressant–placebo differences in 16

Antidepressant–placebo differences in 16 clinical trials over 10

✍ Arif Khan; Amritha Bhat; James Faucett; Russell Kolts; Walter A. Brown 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 104 KB

Can we get the necessary clinical trials

Can we get the necessary clinical trials in children and avoid the unnecessary ones?

✍ Kalle Hoppu 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 49 KB

Does elimination of placebo responders i

Does elimination of placebo responders in a placebo run-in increase the treatment effect in randomized clinical trials? A meta-analytic evaluation

✍ Sandra Lee; John R. Walker; Laura Jakul; Kathryn Sexton 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

The use of a placebo run-in phase, in which placebo responders are withdrawn from a study before random assignment to treatment condition, has been criticized as favoring the active treatment in clinical trials. We compared the effect size of randomized, placebo-controlled clinical trials (in the tr